What The UK’s “Non-Statutory” AI Regulatory Framework Means For Medtech

The UK government has proposed a “pro-innovation” AI regulation strategy, which will utilize the expertise of existing regulators and avoid new legislation. But what does this mean for the medtech sector, and how does the UK approach differ from the EU’s AI Act?

UK AI
• Source: Shutterstock

Authorities across the world have been grappling in recent months with the need to develop suitable regulation for artificial intelligence (AI) products, and the UK has finally announced its plans to introduce an AI framework that is not legally binding. It plans to enable existing regulators to determine how the principles set out in the framework should apply to products within their sectors, rather than setting rules for AI technology in general.

For the medtech sector this may be welcome news, as many experts have warned that implementing heavy AI-related legislation could...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe